PMC:7200337 / 116849-118019 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T665 372-378 Disease denotes Cancer http://purl.obolibrary.org/obo/MONDO_0004992
T666 782-788 Disease denotes Cancer http://purl.obolibrary.org/obo/MONDO_0004992

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T155 116-118 http://purl.obolibrary.org/obo/CLO_0007622 denotes MD
T156 1110-1113 http://purl.obolibrary.org/obo/CLO_0051582 denotes has

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T99834 116-118 Chemical denotes MD http://purl.obolibrary.org/obo/CHEBI_74699
T22358 620-624 Chemical denotes Neon http://purl.obolibrary.org/obo/CHEBI_33310
T75 958-965 Chemical denotes Celsius http://purl.obolibrary.org/obo/CHEBI_145500

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T62 372-378 Phenotype denotes Cancer http://purl.obolibrary.org/obo/HP_0002664
T63 782-788 Phenotype denotes Cancer http://purl.obolibrary.org/obo/HP_0002664

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T692 0-15 Sentence denotes Acknowledgments
T693 16-98 Sentence denotes We apologize to all authors whose work we could not cite due to space limitations.
T694 99-202 Sentence denotes Trainee (PhD and MD/PhD or postdocs) and faculty contributing authors are listed in alphabetical order.
T695 203-231 Sentence denotes Illustrations are by Jill K.
T696 232-294 Sentence denotes Gregory and used with permission of Mount Sinai Health System.
T697 295-550 Sentence denotes We would like to acknowledge funding sources including Fastgrant (M.M.), NCI Cancer Center Support Grant Supplement (M.M., R.M.S.) Burroughs Wellcome Fund (R.M.S.), NIH Director’s Early Independence Award (R.M.S.) and NIH R01AI081848 (N.V., N.B., B.D.G.).
T698 552-576 Sentence denotes Declaration of Interests
T699 577-803 Sentence denotes N.B. serves as an advisor/board member for Neon, Checkpoint Sciences, Primevax, Novartis, Array BioPharma, Roche, Avidea, Boeringer Ingelheim, Rome Therapeutics, Roswell Park, and the Parker Institute for Cancer Immunotherapy.
T700 804-914 Sentence denotes N.B. receives research support from the Parker Insitute, Novocure, Celldex, Genentech, Oncovir, and Regeneron.
T701 915-1034 Sentence denotes M.M. serves as an advisor/board member for Celsius, Pionyr, Compugen, Myeloids and Innate pharma and ad hoc for Takeda.
T702 1035-1104 Sentence denotes M.M. receives research support from Regeneron, Takeda, and Genentech.
T703 1105-1170 Sentence denotes A.M. has equity in Gilead Sciences and Regeneron Pharmaceuticals.